Literature DB >> 15537574

The staging of colorectal cancer: 2004 and beyond.

Carolyn C Compton1, Frederick L Greene.   

Abstract

Stage is the strongest predictor of survival for patients with colorectal cancer. Accurate staging also is critical for appropriate patient management and meaningful clinical research. Uniform staging criteria applied in a uniform manner are essential for accurate evaluation of therapies and outcomes. Historically, numerous different staging systems for colorectal cancer have been employed, but a single internationally recognized system is required to ensure a common language for cancer that is understood by clinicians in all specialties. For the tumor, node, metastasis system to remain relevant, it has to continuously undergo critical evaluation and change when clinically indicated.

Entities:  

Mesh:

Year:  2004        PMID: 15537574     DOI: 10.3322/canjclin.54.6.295

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  130 in total

1.  Molecular staging estimates occult tumor burden in colorectal cancer.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  Adv Clin Chem       Date:  2010       Impact factor: 5.394

2.  Integration of genetic signature and TNM staging system for predicting the relapse of locally advanced colorectal cancer.

Authors:  Junjie Peng; Zhimin Wang; Wei Chen; Yin Ding; Haifeng Wang; Hongjie Huang; Wei Huang; Sanjun Cai
Journal:  Int J Colorectal Dis       Date:  2010-08-13       Impact factor: 2.571

3.  Discovery and verification of gelsolin as a potential biomarker of colorectal adenocarcinoma in the Chinese population: Examining differential protein expression using an iTRAQ labelling-based proteomics approach.

Authors:  Nai-Jun Fan; Chun-Fang Gao; Chang-Song Wang; Jing-Jing Lv; Guang Zhao; Xin-Hua Sheng; Xiu-Li Wang; Dong-Hui Li; Qing-Yin Liu; Jian Yin
Journal:  Can J Gastroenterol       Date:  2012-01       Impact factor: 3.522

4.  A Modified Classification of Prognostic Factors Based on Pathological Stage and Tumor Regression Grade in Patients with Rectal Cancer Who Receive Preoperative Chemoradiotherapy.

Authors:  Toshiyuki Suzuki; Sotaro Sadahiro; Akira Tanaka; Kazutake Okada; Gota Saito; Hiroshi Miyakita; Takeshi Akiba; Hiroshi Yamamuro
Journal:  Oncology       Date:  2017-07-21       Impact factor: 2.935

5.  Heterogeneity of pT3 colorectal carcinomas according to the depth of invasion.

Authors:  Rita Bori; István Sejben; Mihály Svébis; Kornél Vajda; László Markó; Gábor Pajkos; Gábor Cserni
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

Review 6.  Guanylyl cyclase C as a biomarker in colorectal cancer.

Authors:  Terry Hyslop; Scott A Waldman
Journal:  Biomark Med       Date:  2013-02       Impact factor: 2.851

7.  Proposal of a new classification for stage III colorectal cancer based on the number and ratio of metastatic lymph nodes.

Authors:  Li-Ping Wang; Hong-Yan Wang; Rui Cao; Cong Zhu; Xiong-Zhi Wu
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

Review 8.  Genomic era diagnosis and management of hereditary and sporadic colon cancer.

Authors:  Edward David Esplin; Michael Paul Snyder
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 9.  Epidemiology and management options for colorectal cancer in children.

Authors:  Raya Saab; Wayne L Furman
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

10.  Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.